PAMBUKU, ARDI

PAMBUKU, ARDI  

Mostra records
Risultati 1 - 11 di 11 (tempo di esecuzione: 0.019 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Advanced Adrenocortical Carcinoma: From Symptoms Control to Palliative Care 2022 Ruggiero, ElenaTizianel, IreneCaccese, MarioLombardi, GiuseppePambuku, ArdiZagonel, VittorinaScaroni, CarlaCeccato, Filippo + CANCERS - -
An overview of fotemustine in high-grade gliomas: from single agent to association with bevacizumab. 2014 LOMBARDI, GIUSEPPEFARINA, PATRIZIADELLA PUPPA, ALESSANDROCECCHIN, DIEGOPAMBUKU, ARDI + BIOMED RESEARCH INTERNATIONAL - -
Clinical outcome of an alternative fotemustine schedule in elderly patients with recurrent glioblastoma: a mono-institutional retrospective study 2016 Lombardi, GiuseppeBellu, LuisaPambuku, ArdiDella Puppa, AlessandroD’Avella, DomenicoZagonel, Vittorina + JOURNAL OF NEURO-ONCOLOGY - -
Diagnostic Value of Plasma and Urinary 2-Hydroxyglutarate to Identify Patients With Isocitrate Dehydrogenase-Mutated Glioma 2015 LOMBARDI, GIUSEPPEPAMBUKU, ARDID'AVELLA, DOMENICO + THE ONCOLOGIST - -
Effectiveness of antiangiogenic drugs in glioblastoma patients: A systematic review and meta-analysis of randomized clinical trials 2017 LOMBARDI, GIUSEPPEPAMBUKU, ARDIBELLU, LUISADELLA PUPPA, ALESSANDRODENARO, LUCAZAGONEL, VITTORINA + CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY - -
Genetic, epigenetic and immunologic profiling of MMR-deficient relapsed glioblastoma 2019 Indraccolo, StefanoLombardi, GiuseppeFassan, MatteoGiunco, SilviaGasparini, AlessandraFanelli, Giuseppe NicolòPambuku, ArdiD'Avella, DomenicoGardiman, Marina PDe Rossi, AnitaZagonel, Vittorina + CLINICAL CANCER RESEARCH - -
Good tolerability of maintenance temozolomide in glioblastoma patients after severe hematological toxicity during concomitant radiotherapy and temozolomide treatment: report of two cases 2018 Lombardi, GiuseppeCACCESE, MARIOBellu, LuisaPambuku, ArdiBerti, FrancoGardiman, Marina PDenaro, LucaZagonel, Vittorina + ANTI-CANCER DRUGS - -
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial 2019 Bellu L.Pambuku A.Indraccolo S.Gardiman M. P.Zagonel V. + THE LANCET ONCOLOGY - -
Suspicious for recurrent low and high grade glioma and indeterminate MRI: the role of 18F-DOPA PET/CT 2017 Cuppari, L.Lombardi, G.Evangelista, L.Pambuku, A.Saladini, G.Zagonel, V. ANNALS OF ONCOLOGY - -
Temozolomide cytoreductive treatment in a giant cabergoline-resistant prolactin-secreting pituitary neuroendocrine tumor 2019 Ceccato, FilippoLombardi, GiuseppeAlbiger, NoraMazzai, LindaPambuku, ArdiRolma, GiuseppeZagonel, VittorinaScaroni, Carla ANTI-CANCER DRUGS - -
Temozolomide treatment of a malignant pheochromocytoma and an unresectable MAX-related paraganglioma 2018 Lombardi, GiuseppePambuku, ArdiBertorelle, RobertaSchiavi, FrancescaIacobone, MaurizioOpocher, GiuseppeZagonel, Vittorina + ANTI-CANCER DRUGS - -